Head-to-head · WeighScore
Found vs VivioMD
The verdict
Found takes it — 83.5/100 to 57.4/100.
Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The broadest medication bench in the ranking — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Found | VivioMD |
|---|---|---|
| WeighScore | 83.5/100 | 57.4/100 |
| Grade | B | C |
| Site position | #9 | #450 |
| Semaglutide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still precedes a ~$30 per-visit copay | GLP-1 injection advertised from $299/mo; confirm formulation |
| Tirzepatide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules | GLP-1+GIP injection advertised from $398/mo; confirm formulation |
| Coverage | All 50 states | Terms exclude Louisiana; homepage says all 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #9 · B
Strengths
- Widest medication list in this ranking — compounded semaglutide and tirzepatide, brand Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Victoza, plus oral Foundayo (orforglipron) and Rybelsus
- Flat pricing as the dose increases, so a titration does not raise the monthly cost
- Bills insurance for the clinical visits — the site states most members pay under $30 per visit
- Runs a dedicated GLP-1 microdose program for people who want a lower starting dose
Where it loses points
- The $99/mo headline is a longer-plan floor — Found's own FAQ says 3, 6 and 12-month plans are what keep the monthly cost down, so month-to-month costs meaningfully more
- Medication cost is separate from the membership and clinical care, so no advertised figure is the all-in number
- The homepage insurance selector lists roughly 41 states, not 50 — coverage is narrower than the service footprint
- Compounded medication is not FDA-approved the way brand Wegovy or Zepbound are
Site position #450 · C
FDAWarning letter issued to VivioMD Group LLC dba VivioMD in June 2026. See the FDA warning-letter database.
Strengths
- Advertises GLP-1 tablets and injections plus branded Ozempic
- Terms identify OpenLoop clinical groups and RedRock, Health Warehouse and Triad Rx pharmacies
- Refund policy describes refunds for unused prepaid months without medication shipments
Where it loses points
- Terms exclude Louisiana despite nationwide homepage language
- Cancellation requests must arrive at least 72 hours before the next bill
- Headline GLP-1 product names do not specify the exact compounded formulation
- Compounded medications are not FDA-approved
Featured provider
Found
Found scores 83.5/100 (B). The broadest medication bench in the ranking — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.